Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Icu Medical Inc. (ICUI:NASDAQ), powered by AI.
Icu Medical Inc. is currently trading at $142.41. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Icu Medical Inc. on Alpha Lenz.
Icu Medical Inc.'s P/E ratio is 4793.7.
“Icu Medical Inc. trades at a P/E of 4793.7 (premium valuation) with modest ROE of 0.0%.”
Ask for details →Icu Medical Inc. is a healthcare technology company primarily focused on the development, manufacturing, and sale of innovative medical devices and systems used in infusion therapy and critical care applications. The company provides a range of products that include infusion pumps, infusion sets, and needle-free connectors, all designed to enhance patient safety and healthcare efficiency. With a strong presence in hospitals and other healthcare facilities, Icu Medical Inc. plays a pivotal role in meeting the demanding needs of healthcare professionals in delivering intravenous therapies. The company's emphasis on research and development has led to a reputation for high-quality and reliable medical solutions. Its impact is significant across sectors such as acute care, oncology, and pharmaceuticals, supporting the advancement of patient care globally. In the financial market, Icu Medical Inc. is recognized for its contributions to the healthcare industry, reflecting broader trends in medical innovation and technology.
“Icu Medical Inc. trades at a P/E of 4793.7 (premium valuation) with modest ROE of 0.0%.”
Ask for details →Icu Medical Inc. (ticker: ICUI) is a company listed on NASDAQ in the Healthcare sector (Medical Instruments & Supplies). It has approximately 15,000 employees. Market cap is $3.5B.
The current price is $142.41 with a P/E ratio of 4,793.69x and P/B of 1.65x.
ROE is 0.04% and operating margin is 4.90%. Annual revenue is $2.2B.